REALATED ARTICLES

Click on a word or phrase in our Tag Cloud and see all related articles listed below.

Current tag:

Autochthon Biotechnology

Commercialisation Strategies for Functional Food, Feed and Biofuels from Algae

(C) Wolf G Kroner 2012 April 2012. In order to turn algal biomass into a commodity product current cost is to be significantly brought down. Dr James Flatt, CTO of Synthetic Genomics provides in-depth answers to probing questions by B2Bioworld about SGI’s R&D strategies, its business case, social responsibility and returns to investors – including Agradis and developing countries.

System Biology: In search of good questions

Prof. Walter Kolch on the approach taken by Systems Biology Ireland

Prospects of Enzyme Engineering and Biofuels Markets in Russia

Vladimir O. Popov, Director Bach Institute of Biochemistry, Moscow

Extraction of Nutraceutical Components from Algae Using Supercritical CO2

Nadine Igl-Schmid, Josef Schulmeyr, Andreas Wuzik, Technical article peer reviewed & revised by authors of NATECO2 (Joh. Barth & Sohn)

Teeth for the Convention on Biological Diversity

Christian Wichard, Deputy Director-General of WIPO on its role in enforcing access and benefit sharing

Systems Biology Applied

The Need of Systems Theory Thinking in Using Technologies and Pitfalls of Some Concepts. Prof. Rudi Balling, Luxembourg Centre for Systems Biomedicine

Plants are Nature’s Best Chemists

Plant Genetic Engineering:”It’s not as simple as Yes or No!”

Nobel Prize winner Prof. Christiane Nüsslein-Volhard Warns of GMO-populism and researchers not standing up

Direvo: Cash in Agbio and Food Markets

Jörg Riesmeier, Direvo’s COO describes near- to mid-term strategies

Roche Ethiopia: Build-up of an emerging market

Turkey’s Chemicals Industry in Search of Modernisation

If you would like to read more, please proceed to the download section.

Important: After pressing "Buy this article (PayPal)" below you will be taken to the PaypPal checkout page. There you must press the orange "Return To BioBusinessMedia" button in order to download your article.
In buying this article you agree with our Terms & Conditions which you can consult here.

Lilly Ventures: Is it worth a dollar, or a million dollars?

Ed Torres, Managing Director of Lilly Ventures on the fund’s input to Eli Lilly’s business development

S. Edward Torres December 2010. What strategies is Lilly’s Venture Fund pursuing in the US and Latin America. Ed Torres, Managing Director of Lilly Ventures describes for B2Bioworld investment policies in biotechnology, medical technologies, and healthcare IT, as well as future plans. There will be a marked change with regard to the Fund’s approach in Europe. But what is at stake, when non-profit organisations have a major say? Moreover, what is the critical input to the parent company in developing its global business and filling up the pipeline. Includes a detailed overview on current investments as well as co-investors compiled by B2Bioworld.